Genelux

GNLXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$118.090 M

$2.61 +1.95%

Close of 22 Sept 2026

Revenue

$8.00K

#3626 by revenue

Earnings

-$32.1M

Loss-making

Shares outstanding

45,245,335

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#299EquilliumEQ$122.4M
#300ProMIS NeurosciencesPMN$121.8M
#301GeneluxGNLX$118.1M
#302Milestone PharmaceuticalsMIST$114.7M
#303PMV PharmaceuticalsPMVP$114.0M

What if Genelux were worth as much as…

Open the what-if tool →

Gold $30.2T

$668,222.92

Per share 256,024× higher

Bitcoin $1.74T

$38,493.58

Per share 14,748× higher

Nvidia $5.52T

$121,907.97

Per share 46,708× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Genelux are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.